Estrogens and prostatic disease

Prostate

Volumn 45, Issue 2, 2000, Pages 87-100

  Griffiths, Keith ^a,b  

^a Oncology Centre of Antwerp   (Belgium)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR BETA; PHYTOESTROGEN; SOMATOMEDIN C; TAMOXIFEN;

AFRICA; AGING; ANGIOGENESIS; CELL INTERACTION; DIETARY INTAKE; EPITHELIUM CELL; ESTROGEN ACTIVITY; GENOME IMPRINTING; GROWTH REGULATION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; UNITED STATES;

AGING; BLACKS; DISEASE PROGRESSION; EPITHELIAL CELLS; ESTROGENS; GENOMIC IMPRINTING; HUMAN; MALE; NEOVASCULARIZATION, PATHOLOGIC; PREVALENCE; PROSTATE; PROSTATIC DISEASES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; SOMATOMEDINS; STROMAL CELLS; SUPPORT, NON-U.S. GOV'T; UNITED STATES;

EID: 0033814734     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20001001)45:2<87::AID-PROS2>3.0.CO;2-G     Document Type: Review

References (91)

1. Introduction
2. Epidemiology and natural history of prostate cancer
3. Phyto-oestrogens and Western diseases
4. Possible relationship between dietary factors and pathogenesis of prostate cancer
5. Invited viewpoints
6. Endocrine treatment in prostate cancer
7. Growth regulation of normal and malignant prostatic cells
8. Regulation of prostate growth
9. Steroid 5alpha-reductase deficiency in man: An inherited form of male pseudohermaphroditism
10. A comparative study of the ultrastructure and lack of growth capacity of adult human prostate epithelium mechanically separated from its stroma
11. The endocrinology and developmental biology of the prostate
12. Androgens and estrogens: Their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate
13. Steroids of adrenal origin metabolized by human prostate tissue, both in vivo and in vitro
14. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy
15. Prostatic ductal system in rats: Regional variation in morphological and functional activities
16. Effect of aging on endogenous level of 5α-hihydrotestosterone, testosterone, estradiol and estrone in epithelium and stroma of normal and hyperplastic human prostate
17. Simultaneous quantitative analysis of prostate sex steroids and comparison with human prostatic histological composition
18. The induction of prostatic hypertrophy in the dog with androstanediol
19. The development of human benign prostatic hyperplasia with age
20. Origin and evolution of benign prostatic enlargement
21. Testosterone secretion and metabolism in male senescence
22. Androgens in male senescence
23. Latent carcinoma of the prostate at autopsy in seven areas
24. Geographic pathology of latent prostatic cancer
25. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients
26. Prostatic intraepithelial neoplasia: A marker for high-risk groups and a potential target for chemoprevention
27. Diet and its preventive role in prostatic disease
28. Prostate cancer and diet: Investigations, interventions and future considerations
29. Bimodal age-frequency distribution of epitheliosis in cancer mastectomies
30. Pharmacology and clinical uses of testosterone
31. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
32. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
33. Estrogen receptor beta mRNA ontogeny in the prostate of normal and neonatally estrogenized rats
34. Estrogen receptor-beta: Implications for the prostate gland
35. Nuclear receptor co-activators and corepressors
36. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a base for the cell- and promoter-specific action of these hormones
37. Differential ligand activation of estrogen receptors ER alpha and ER beta at AP-1 sites
38. 70, for the androgen receptor in human prostate cells
39. Adenocarcinoma of the vagina: Association of maternal stilboestrol therapy with tumor appearance in young women
40. Hypothesis: Does breast cancer originate in utero?
41. The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth
42. Oestrogens and the prostate gland
43. Epigenetic inheritance: The chromatin connection
44. Parental imprinting of the mouse insulin-like growth factor II gene
45. The essentials of DNA methylation
46. Relaxation of imrinted genes in human cancer
47. Prostate enlargement in mice due to fetal exposure to low doses of estradiol of diethylstilbestrol and opposite effects at high doses
48. The early in utero oestrogen and testosterone environment of blacks and whites: Potential effects on male offspring
49. Insulin-like growth factors and their binding proteins: Biological actions
50. Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development
51. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
52. Insulin-like growth factor-I and prostate cancer risk: A population-based case control study
53. Effect of growth hormone (GH) and insulin-like growth factor-I on prostatic diseases: An ultrasonographic and endocrine study in acromegaly, GH deficiency and healthy subjects
54. Insulin-like growth factors
55. IGFBPs and their role in controlling IGF actions
56. Prostate specific antigen (PSA) is an insulin-like growth factor binding protein 3-like protease found in seminal plasma
57. Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells
58. The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostate stromal cells
59. The insulin-like growth factor-I receptor: A key to tumour growth
60. Culture of prostate epithelial cells of the rhesus monkey on extra-cellular matrix substrate: Influence of steroid and insulin-like growth factors
61. Systemic administration of insulin-like growth factor (IGF-I) causes growth of the rat prostate
62. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4 and 5
63. Estrogen regulation of the insulin-like growth factor-I gene transcription involves an AP-1 enhancer
64. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
65. Phyto-oestrogens and inhibition of angiogenesis
66. Reactive oxygen metabolites and reperfusion injury: Aberrant triggering of reticuloendothelial function
67. bFGF and tumor angiogenesis: Back in the limelight?
68. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats
69. The hemostatic system as a regulator of angiogenesis
70. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids
71. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo
72. Prostate innervation
73. Induction of prostate apopotosis by doxazosin in benign prostatic hyperplasia and prostate cancer
74. Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death
75. Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells
76. Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β) type I and II receptors in human prostate cancer
77. Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF-beta 1 and bcl-2 expression
78. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
79. Mechanism of activation of the TGF-β receptor
80. Growth inhibition of TGF-beta linked to suppression of retinoblastoma protein phosphorylation
81. Inhibition of growth by transforming growth factor-β following fusion of two non-responsive human carcinoma cell lines
82. Restoration of transforming growth factor β signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis
83. A phase II study of high-dose tamoxifen in patients with hormone refractory prostate cancer
84. The effect of citrus flavonoids on tumor invasion and metastasis
85. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype
86. Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer
87. Effects of mepartricin, a polyene macrolide agent, on fecal excretion and serum concentrations of estrogen and on number of estrogen receptors in immature rats
88. Double-blind, placebo-controlled trial to test the efficacy and tolerability of mepartracin in the treatment of BPH